March 29, 2022
The US Food and Drug Administration (FDA) has approved fenfluramine (Fintepla) oral solution, a Schedule IV controlled substance, for the treatment of seizures associated with Lennox-Gastaut […]
March 29, 2022
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways The burden of self-reported […]
March 29, 2022
Adults with pre-existing dementia or disability who suffer acute ischemic stroke can benefit from endovascular therapy (EVT) or thrombolysis, the American Heart Association (AHA)/American Stroke Association […]
March 29, 2022
The study covered in this summary was published on bioRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Aggregates of phosphorylated TAR […]
March 24, 2022
An experimental brain-computer interface has allowed a man with amyotrophic lateral sclerosis (ALS) who was unable to speak or move to communicate. Using a commercially available […]
March 24, 2022
About 1 in 6 patients with Creutzfeldt-Jakob disease (CJD) undergo surgery, raising the risk of iatrogenic transmission of this rare but universally fatal prion disease. In […]
March 23, 2022
The study covered in this summary was published in Research Square as a preprint and has not yet been peer reviewed. Key Takeaways For patients with […]
March 23, 2022
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways The study determined that […]
March 22, 2022
Differing state regulations and a paucity of research has made it difficult to develop consensus guidelines for the use of cannabinoids in treating drug-resistant epilepsy. A […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131
Next page